RachelBuchsbaumMD

Oncology • Boston, MA

Breast Cancer, Hematologic Oncology

Chief, Division of Hematology Oncology, Tufts Medical Center

Join to view full profile

Dr. Buchsbaum is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Buchsbaum's full profile

Already have an account?

Office
750 Washington St
Boston, MA 02111
Phone+1 617-636-5000

Fax+1 617-636-8538

Education & Training

Tufts Medical CenterFellowship, Hematology and Medical Oncology, 1988 - 1992
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1985 - 1988
Weill Cornell MedicineClass of 1985
Harvard UniversityA.B., Chemistry & Physics, Cum Laude, 1980

Certifications & Licensure

MA State Medical License 1987 - 2025
NH State Medical License 2024 - 2024
ME State Medical License 2020 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Exceptional Women in Medicine Castle Connolly, 2017
Boston's Top Doctors Boston Magazine, 2017
Zucker Clinical Teaching Prize for Innovation in Medical Education Tufts University School of Medicine, 2015

Publications & Presentations

PubMed

DNA Methylation-Derived Immune Cell Proportions and Cancer Risk in Black Participants.
Christopher S Semancik, Naisi Zhao, Devin C Koestler, Eric Boerwinkle, Jan Bressler
Cancer Research Communications. 2024-10-01
Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.
Nicholas D Camarda, Qing Lu, Dawn M Meola, Joshua J Man, Zeyuan Song
Clinical Science. 2024-09-18
DNA Methylation-Derived Immune Cell Proportions and Cancer Risk, Including Lung Cancer, in Black Participants.
Christopher S Semancik, Naisi Zhao, Devin C Koestler, Eric Boerwinkle, Jan Bressler
Medrxiv. 2024-05-09

Abstracts/Posters

Supervised Machine Learning Algorithms Using Patient Related Factors to Predict in-Hospital Mortality Following Acute Myeloid Leukemia Therapy
Rachel J. Buchsbaum, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

Fulfilling Common Program Requirements VI.C: Well-Being
ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019

Press Mentions

Debunking Myths About CancerJune 10th, 2022
Efficacy of Margetuximab vs Trastuzumab in Patients with Pretreated ERBB2-Positive Advanced Breast CancerJanuary 22nd, 2021